Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Immage Biotherapeutics Corp. (OTC: IMMG).

Full DD Report for IMMG

You must become a subscriber to view this report.



Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-14N/A0.001N/AN/A0
2018-12-13N/A0.001N/AN/A0
2018-12-12N/A0.001N/AN/A0
2018-12-11N/A0.001N/AN/A0
2018-12-10N/A0.001N/AN/A0

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-226,1006,100100.0000Short
2017-10-0511,57511,575100.0000Short
2017-06-1425,00026,25295.2308Short
2017-06-1315,00030,00050.0000Short
2017-05-2210,00017,72156.4302Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on IMMG.


About Immage Biotherapeutics Corp. (OTC: IMMG)

Logo for Immage Biotherapeutics Corp. (OTC: IMMG)

Immage Biotherapeutics is a biotechnology company developing cancer immunotherapy through the rapid and efficient development of cutting edge immunotherapy candidates. The company is in the process of developing novel key cancer immunotherapy candidates that can be licensed to the biotechnology and pharmaceutical industry, allowing them the opportunity to develop in vitro proven treatments.

 

Contact Information

 

 

Current Management

  • Anton Dormer / CSO
  • Mou Zhi Cong / CEO
  • Mahesh Narayanan / COO
  • Elton Norman / CFO
  • Dr. Daniel Achinko / EVP
  • Dr. William M. Brown, Ph.D, M.B.A., / Advisory Director
  • Georgia M. Dunston / Advisory Director
  • Dr. Tamaro Hudson / Advisory Director
  • Dr. Stephen Popielarski / Advisory Director
  • Anton Dormer / Chairman
  • Mou Zhi Cong /
  • Mahesh Narayanan /
  • Elton Norman /

Current Share Structure

  • Market Cap: $91,047 - 03/13/2018
  • Authorized: 200,000,000 - 12/12/2016
  • Issue and Outstanding: 151,744,566 - 12/30/2016
  • Float: 40,142,136 - 12/12/2016

 



Daily Technical Chart for (OTC: IMMG)

Daily Technical Chart for (OTC: IMMG)


Stay tuned for daily updates and more on (OTC: IMMG)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: IMMG)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in IMMG is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of IMMG and does not buy, sell, or trade any shares of IMMG. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/